Empagliflozin Induces Transient Diuresis Without Changing Long-Term Overall Fluid Balance in Japanese Patients With Type 2 Diabetes

INTRODUCTION: Empagliflozin, a sodium glucose co-transporter 2 (SGLT2) inhibitor, ameliorates hyperglycemia in patients with type 2 diabetes (T2D) by inducing sustained glucosuria. Empagliflozin treatment was previously associated with a transient increase in 24-h urine volume in Caucasian patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Yasui, Atsutaka, Lee, Ganghyuck, Hirase, Tetsuaki, Kaneko, Tatsuroh, Kaspers, Stefan, von Eynatten, Maximilian, Okamura, Tomoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104279/
https://www.ncbi.nlm.nih.gov/pubmed/29488164
http://dx.doi.org/10.1007/s13300-018-0385-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104279/
https://www.ncbi.nlm.nih.gov/pubmed/29488164
http://dx.doi.org/10.1007/s13300-018-0385-5

Ejemplares similares